SCHEMBL28458171

SCHEMBL28458171

CC(C)(C)OC(=O)Nc1ncc(B2OC(C)(C)C(C)(C)O2)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.56
AAK1 Q2M2I8 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
LCK P06239 3/20 0.39
CCNB2 O95067 1/20 0.39
CCNE2 O96020 1/20 0.39
CDK1 P06493 1/20 0.39
CDK4 P11802 1/20 0.39
CCNB1 P14635 1/20 0.39
CCND1 P24385 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
PARG Q86W56 1/20 0.39
FPR3 P25089 2/20 0.38
FPR2 P25090 2/20 0.38
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3697678 0.81 USP30 (0.44) USP30CA1CA2CCNE1CDK2
SCHEMBL31418598 0.77 USP30 (0.41) USP30AAK1CA1CA2LCK
SCHEMBL31418506 0.77 USP30 (0.41) USP30AAK1CA1CA2LCK
SCHEMBL31512022 0.77 USP30 (0.44) USP30AAK1CA1LCKPRMT5
SCHEMBL35210589 0.76 USP30 (0.43) USP30AAK1CA1CA2LCK
SCHEMBL1367326 0.76 USP30 (0.77) USP30AAK1PRMT5WDR77DGAT1
SCHEMBL640631 0.76 FFAR2 (0.52) CA1CA2LCKCCNB2CCNE2
SCHEMBL13266901 0.76 CA1 (0.47) CA1CA2LCKCCNB2CCNE2
SCHEMBL1180976 0.75 AAK1 (0.47) USP30AAK1PRMT5WDR77DGAT1
SCHEMBL31167785 0.75 LCK (0.42) USP30AAK1LCKPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108699035-B Novel compounds 特殊治疗有限公司 2021-10-15 CN disclosed
CN-108290872-B Cyanopyrrolidine derivatives as DUBs inhibitors 特殊治疗有限公司 2020-10-02 CN disclosed